ArticleInternational journal of hematology2021

Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.

Fumi Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.